A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction - Ejemel, Monir; Li, Qi; Hou, Shurong; Schiller, Zachary A.; Tree, Julia A.; Wallace, Aaron; Amcheslavsky, Alla; Kurt Yilmaz, Nese; Buttigieg, Karen R.; Elmore, Michael J.; Godwin, Kerry; Coombes, Naomi; et al. (Nature communications, 2020)
Keywords: 101/1; 631/154/51/1568; 631/250/255/2514; 631/250/347; 631/535/1267; 82/1; ACE2; Angiotensin-Converting Enzyme 2; Animals; Antibodies; Antibodies, Monoclonal - immunology; Antibodies, Monoclonal - metabolism; Antibodies, Neutralizing - immunology; Antibodies, Neutralizing - metabolism; Betacoronavirus - immunology; Binding; Chlorocebus aethiops; COVID-19; Cross Reactions; Epitopes; HEK293 Cells; Humanities and Social Sciences; Humans; Immunity; Immunoglobulin A; Immunoglobulin A - immunology; Immunoglobulin A - metabolism; Immunoglobulin A, Secretory - immunology; Immunoglobulin A, Secretory - metabolism; Immunoglobulin G; Immunoglobulin G - immunology; Immunoglobulin G - metabolism; Models, Molecular; Monoclonal antibodies; Morbidity; Mucosal immunity; multidisciplinary; Mutation; Neutralization; Pandemics; Peptidyl-Dipeptidase A - metabolism; Protein Binding; Protein Interaction Domains and Motifs; Receptors; Respiratory system; SARS-CoV-2; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Severe acute respiratory syndrome-related coronavirus - immunology; Spike Glycoprotein, Coronavirus - chemistry; Spike Glycoprotein, Coronavirus - genetics; Spike Glycoprotein, Coronavirus - immunology; Spike Glycoprotein, Coronavirus - metabolism; Vaccines; Vero Cells; Viral diseases; Viruses